This week we’ve seen a slew of startup financings and an IPO in the New England area.
—Third Rock Ventures became an investor in Taris Biomedical, leading an $18.3 million Series B financing for the MIT spinout. The company will use the money to advance its drug-delivery device, for treating a variety of bladder ailments.
—Needham, MA-based CAD and product development software firm PTC (NASDAQ: PMTC) said that it bought MKS for CDN$292.5 million, at CDN$26.20 per share in cash. MKS (TSX: MKXX) provides technology for managing the development of software applications.
—Currensee, a Boston-based provider of online tools for investors interested in foreign markets, said it raised $4 million in Series C funding, from North Bridge Venture Partners, Egan-Managed Capital, and Vernon & Park Capital.
—Cambridge, MA-based car-sharing company Zipcar (NASDAQ: ZIP) went public, offering 9.7 million shares at $18 per share. Zipcar raised $174.3 million in the deal, which was an increase over the 8.3 million shares the company originally planned to offer at $14 to $16 per share.
—Cambridge-based Merrimack Pharmaceuticals announced it had raised $77 million in a Series G round of funding, to put toward its pipeline of … Next Page »